Intervention not reported
Overall survival median · Adults with recurrent HGG
The intervention showed no clear difference in overall survival median (moderate certainty).
1 finding from 1 review
- Procarbazine, lomustine and vincristine for recurrent high‐grade glioma 2017 · Cochrane Headline outcomes onlyHR 0.91 [0.74, 1.11]1 study · 447 participantsModerate